Atlas FDA

Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account

Paragon Diagnostics, Inc. — Predicate Candidate Screening

7 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.

44 daysmedian FDA review time
119 days90th percentile
7clearances measured
K-numberDeviceApplicantDecidedReview daysRecalls (K-match)
K841162IMMPULSE GENTAMICIN ASSAY REAGENTSParagon Diagnostics, Inc.1984-05-02440
K841161IMMPULSE AMIKACIN ASSAY REAGENTSParagon Diagnostics, Inc.1984-05-02440
K840852IMMPULSE T4 ASSAY REAGENTSParagon Diagnostics, Inc.1984-04-18540
K840847IMMPULSE TOBRAMYCIN ASSAY REAGENTSParagon Diagnostics, Inc.1984-04-04400
K840758IMMPULSE THEOPHYLLINE ASSAY REAGENTSParagon Diagnostics, Inc.1984-04-04410
K840853IMMPULSE TBC ASSAY REAGENTSParagon Diagnostics, Inc.1984-04-01370
K834070IMMPULSE SYSTEMParagon Diagnostics, Inc.1984-03-231190

Methodology

Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.

Prepared with Atlas

Predicate research, review-time statistics and recall monitoring for 510(k) teams — atlasbyauro.com/fda